Gene · 5352
Papers1,610
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,610
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Machine Learning-based Gene Biomarker Identification for Improving Prognosis and Therapy in Hepatocellular Carcinoma. | Curr Med Chem | 2025 | 40183270 | PubTator, text mining | PubMed |
| Lysyl hydroxylase 2 glucosylates collagen VI to drive lung cancer progression. | J Clin Invest | 2025 | 40166934 | PubTator, text mining | PubMed |
| Identification of glycolysis-related gene signatures for prognosis and therapeutic targeting in idiopathic pulmonary fibrosis. | Front Pharmacol | 2025 | 40093327 | PubTator, text mining | PubMed |
| Single-cell RNAseq reveals adverse metabolic transcriptional program in intrahepatic cholangiocarcinoma malignant cells. | Biochem Biophys Rep | 2025 | 40034261 | PubTator, text mining | PubMed |
| Anti-fibrotic effects of thrombin inhibition in systemic sclerosis-associated interstitial lung disease: Proof of concept. | J Scleroderma Relat Disord | 2025 | 40013233 | PubTator, text mining | PubMed |
| Dysregulation of G6PD by HPV E6 exacerbates cervical cancer by activating the STAT3/PLOD2 pathway. | Carcinogenesis | 2025 | 39943705 | PubTator, text mining | PubMed |
| Hypoxia-induced circPLOD2a/b promotes the aggressiveness of glioblastoma by suppressing XIRP1 through binding to HuR. | Commun Biol | 2025 | 39820362 | PubTator, text mining | PubMed |
| Hypoxia-induced translation of collagen-modifying enzymes PLOD2 and P4HA1 is dependent on RBM4 and eIF4E2 in human colon cancer HCT116 cells. | FEBS J | 2025 | 39710969 | PubTator, text mining | PubMed |
| PLOD2 exacerbates cervical squamous cell carcinoma by suppressing p53 by binding to YAP1. | Mol Med Rep | 2025 | 39513600 | PubTator, text mining | PubMed |
| Clinical, genomic, and proteomic perspectives in the analysis of comorbid conditions in type 2 diabetes mellitus: a retrospective study. | Acta Diabetol | 2025 | 39508856 | PubTator, text mining | PubMed |
| DNA methylation of bone morphogenetic protein 7 in leukocytes as a possible biomarker for hand osteoarthritis: A pilot study. | J Orthop Res | 2025 | 39182186 | PubTator, text mining | PubMed |
| A Notch signaling pathway-related gene signature: Characterizing the immune microenvironment and predicting prognosis in hepatocellular carcinoma. | J Transl Int Med | 2024 | 40708676 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing and immune microenvironment analysis reveal PLOD2-driven malignant transformation in cervical cancer. | Front Immunol | 2024 | 39840054 | PubTator, text mining | PubMed |
| Discovery of Glucose Metabolism-Associated Genes in Neuropathic Pain: Insights from Bioinformatics. | Int J Mol Sci | 2024 | 39769264 | PubTator, text mining | PubMed |
| Cellular and Molecular Effects of the Bruck Syndrome-Associated Mutation in the PLOD2 Gene. | Int J Mol Sci | 2024 | 39769143 | Swiss-Prot, curated | PubMed |
| TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study. | J Natl Cancer Cent | 2024 | 39735439 | PubTator, text mining | PubMed |
| Imperfect wound healing sets the stage for chronic diseases. | Science | 2024 | 39636982 | PubTator, text mining | PubMed |
| Eosinophil-Associated Genes are Potential Biomarkers for Hepatocellular Carcinoma Prognosis. | J Cancer | 2024 | 39308686 | PubTator, text mining | PubMed |
| Hypoxia and Foxn1 alter the proteomic signature of dermal fibroblasts to redirect scarless wound healing to scar-forming skin wound healing in Foxn1-/- mice. | BMC Biol | 2024 | 39256768 | PubTator, text mining | PubMed |
| Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer. | BJC Rep | 2024 | 39184453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5352/papers?page=4